| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 11.1 | 15.6 | 15.0 |
| Other income | 0.0 | 0.2 | 0.1 |
| Total income | 11.1 | 15.8 | 15.1 |
| Profit before exceptional items & tax | -0.3 | 1.9 | 1.7 |
| Profit before tax | -0.3 | 1.9 | 1.7 |
| Net profit | -5.2 | 0.4 | 0.5 |
| Operating margin | -2.7% | 12.0% | 11.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -26.00% |
|---|
BSE results filing, BSE: 543453. Figures extracted from the filing.
Alkosign Ltd: key numbers
- Share price
- ₹60.00
- Market cap
- ₹64.76 Cr
- Revenue (annual)
- ₹26.70 Cr
- Net profit (annual)
- ₹-4.76 Cr
- P/E (TTM)
- -13.6×Sector 39.1×
- Promoter holding
- 45.92%
- FII holding
- 9.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alkosign Ltd
All →Alkosign Annual General Meeting
Alkosign Limited has issued a notice for its Annual General Meeting scheduled for September 29, 2026. The meeting will address financial statements and director re-appointments.
Alkosign Annual Report
Alkosign Ltd submitted its Annual Report for FY 2025-26 along with the notice for its 6th Annual General Meeting scheduled on September 29, 2026.
Alkosign Management Change
Alkosign Ltd's board approved the reappointment of Samir Narendra Shah as CMD and Shrenik Kamlesh Shah as WTD. The board also scheduled the 6th AGM for September 29, 2026.
Alkosign Results Correction
Alkosign Ltd revised its audited standalone and consolidated financial results for FY2026 due to typographical errors. The correction ensures accurate financial reporting for investors.
Alkosign Financial Results
Alkosign Ltd approved its FY26 audited standalone and consolidated financial results. The board also re-appointed M/s Shah Gupta & Co. Associates as internal auditors.
Alkosign Board Meeting Date
Alkosign Limited scheduled a board meeting on May 29, 2026, to approve audited financial results. The trading window remains closed until 48 hours post-announcement.